We use cookies to enhance the usability of our website. If you continue, we'll assume that you are happy to receive all cookies. More information. Don't show this again.
The Survival Scatter plot shows the clinical status (i.e. dead or alive) for all individuals in the patient cohort, based on the same data that underlies the corresponding Kaplan-Meier plots. Patients that are alive at last time for follow-up are shown in blue and patients who have died during the study are shown in red.
The x-axis shows the expression levels (FPKM) of the investigated gene in the tumor tissue at the time of diagnosis. The y-axis shows the follow-up time after diagnosis (years). Both axes are complimented with kernel density curves demonstrating the data density over the axes. The top density plot shows the expression levels (FPKM) distribution among dead (red) and alive patients (blue). The right density plot shows the data density of the survived years of dead patients with high and low expression levels respectively, stratified using the cutoff indicated by the vertical dashed line through the Survival Scatter plot. This cutoff is automatically defined based on the FPKM cutoff that minimizes the p-score. The cutoff can be changed by dragging the vertical line or by entering a cutoff value in the square labeled "Current cut-off".
Under the Survival Scatter plot the p-score landscape (black curve; left axis) is shown together with dead median separation (red curve; right axis). Dead median separation is the difference in median mRNA expression between patients who have died with high and low expression, respectively. It is calculated as follows: median FPKM expression of dead patients with high expression - median FPKM expression of dead patients with low expression. This is intended to aid the user in visually exploring custom cutoffs and the associated p-scores and dead median separation.
Individual patient data is displayed and can be filtered by clicking on one or more of the category buttons on the top of the page. Categories describing expression level and patient information include: high, low, alive, dead, female, male and tumor stages. The scale of the x-axis can be toggled between linear and log-scale by clicking on the "x log" button. Mouse-over function shows TCGA ID, patient information and mRNA expression (FPKM) for each patient.
& Survival analysisi
Kaplan-Meier plots summarize results from analysis of correlation between mRNA expression level and patient survival. Patients were divided based on level of expression into one of the two groups "low" (under cut off) or "high" (over cut off). X-axis shows time for survival (years) and y-axis shows the probability of survival, where 1.0 corresponds to 100 percent.
PDP1 is potential prognostic, high expression is unfavorable in Ovary Serous Cystadenocarcinoma (TCGA)
Stage:
Survival analysis
Current cut offi
Current cut-off shows the cut-off (FPKM) currently selected. It may be changed manually. When the current cut-off is changed, the vertical dashed line indicating cut-off, the interactive survival scatter plot and the Kaplan-Meier curve will be automatically adjusted to show results accordingly.
:
Best expression cut offi
Based on the FPKM value of each gene, patients were classified into two groups and association between prognosis (survival) and gene expression (FPKM) was examined. The best expression cut-off refers the FPKM value that yields maximal difference with regard to survival between the two groups at the lowest log-rank P-value. Best expression cut-off was selected based on survival analysis .
When clicking on this number, the vertical dashed line indicating cut-off, the interactive survival plot, and the Kaplan-Meier curve will be adjusted to show results based on the best expression cut-off.
Median expression refers to the median FPKM value calculated based on the gene expression (FPKM) data from all patients in this dataset. When clicking on this number, the vertical dashed line indicating cut-off, the interactive survival plot, and the Kaplan-Meier curve will be adjusted to show results based on the median expression.
Median follow up time refers to the median time (years) after diagnosis with this type of cancer, based on clinical data from all patients in this dataset.
: N/A
P scorei
Log-rank P value for Kaplan-Meier plot showing results from analysis of correlation between mRNA expression level and patient survival.
N/A
5-year survival highi
5-year survival for patients with higher expression than the expression cutoff.
For melanoma and glioma, 3-year survival is shown.
N/A
5-year survival lowi
5-year survival for patients with lower expression than the expression cutoff.
For melanoma and glioma, 3-year survival is shown.
N/A
TCGA RNA samplesi
RNA-seq data is reported as average FPKM (number Fragments Per Kilobase of exon per Million reads), generated by the The Cancer Genome Atlas (TCGA) .
Normal distribution across the dataset is visualized with box plots, shown as median and 25th and 75th percentiles. Points are displayed as outliers if they are above or below 1.5 times the interquartile range. FPKM values of the individual samples are presented next to the box plot.
Average TPM
9.4
Number of samples
349
Samples
Sample
Description
TPM
TCGA-29-1711-01A
0 years, female, black or african american, stage:Stage IIIC, alive, 1053 days
38.3
TCGA-24-1425-01A
0 years, female, white, stage:Stage IIIC, alive, 181 days
35.9
TCGA-25-2404-01A
0 years, female, american indian or alaska native, stage:Stage IIIC, dead, 883 days
35.2
TCGA-61-2113-01A
0 years, female, white, stage:Stage IIC, dead, 676 days
30.2
TCGA-25-2399-01A
0 years, female, white, stage:Stage IIIC, dead, 608 days
28.3
TCGA-57-1584-01A
0 years, female, white, stage:Stage IIIC, alive, 643 days
27.6
TCGA-61-2104-01A
0 years, female, white, stage:Stage IIC, alive, 2338 days
26.1
TCGA-04-1648-01A
0 years, female, white, stage:Stage IIIC, dead, 871 days
24.9
TCGA-29-A5NZ-01A
0 years, female, black or african american, stage:Stage IIIC, dead, 1088 days
24.8
TCGA-24-1105-01A
0 years, female, white, stage:Stage IIIC, dead, 1442 days
24.3
TCGA-57-1993-01A
0 years, female, white, stage:Stage IIIC, alive, 763 days
23.6
TCGA-24-1417-01A
0 years, female, white, stage:Stage IV, alive, 238 days
23.4
TCGA-29-1694-01A
0 years, female, white, stage:Stage IIIC, dead, 1187 days
22.8
TCGA-61-1728-01A
0 years, female, white, stage:Stage IV, alive, 848 days
22.7
TCGA-04-1362-01A
0 years, female, white, stage:Stage IIC, dead, 1348 days
22.5
TCGA-24-1846-01A
0 years, female, stage:Stage IIIC, alive, 133 days
22.5
TCGA-25-1329-01A
0 years, female, white, stage:Stage IIIC, dead, 457 days
22.1
TCGA-61-1724-01A
0 years, female, white, stage:Stage IIIC, dead, 637 days
21.9
TCGA-24-1427-01A
0 years, female, stage:Stage IIIC, alive, 147 days
21.6
TCGA-31-1946-01A
0 years, female, stage:Stage IIIC, alive, 918 days
20.9
TCGA-29-1696-01A
0 years, female, white, stage:Stage IIIC, dead, 1032 days
19.3
TCGA-61-2097-01A
0 years, female, white, stage:Stage IIC, alive, 1844 days
19.3
TCGA-13-1410-01A
0 years, female, white, stage:Stage IV, alive, 2464 days
19.0
TCGA-24-2289-01A
0 years, female, white, stage:Stage IV, dead, 2049 days
19.0
TCGA-24-2298-01A
0 years, female, white, stage:Stage IIIC, dead, 1620 days
18.5
TCGA-59-2355-01A
0 years, female, white, stage:Stage IV, dead, 65 days
18.5
TCGA-25-2042-01A
0 years, female, american indian or alaska native, stage:Stage IIIC, dead, 396 days
18.3
TCGA-25-1318-01A
0 years, female, white, stage:Stage IIIC, dead, 1064 days
18.2
TCGA-29-1710-01A
0 years, female, white, stage:Stage IIIC, dead, 951 days
18.1
TCGA-25-1326-01A
0 years, female, white, stage:Stage IIIC, dead, 1249 days
18.0
TCGA-36-1570-01A
0 years, female, white, stage:Stage IIIC, alive, 655 days
17.9
TCGA-VG-A8LO-01A
0 years, female, black or african american, stage:Stage IV, dead, 24 days
17.9
TCGA-09-1670-01A
0 years, female, white, stage:Stage IIIA, alive, 547 days
17.7
TCGA-24-1563-01A
0 years, female, black or african american, stage:Stage IIIC, dead, 1451 days
17.4
TCGA-59-2354-01A
0 years, female, white, stage:Stage IIIC, dead, 1046 days
17.3
TCGA-30-1857-01A
0 years, female, white, stage:Stage IV, dead, 8 days
17.3
TCGA-25-1623-01A
0 years, female, white, stage:Stage IV, dead, 565 days
17.2
TCGA-24-2254-01A
0 years, female, white, stage:Stage IIIC, dead, 1736 days
17.1
TCGA-24-1557-01A
0 years, female, white, stage:Stage IIIC, dead, 1213 days
16.9
TCGA-25-1628-01A
0 years, female, white, stage:Stage IIIC, dead, 627 days
16.8
TCGA-24-1847-01A
0 years, female, white, stage:Stage IV, alive, 343 days
16.6
TCGA-5X-AA5U-01A
0 years, female, black or african american, stage:Stage IIC, alive, 361 days
16.6
TCGA-13-0726-01A
0 years, female, white, stage:Stage IIIC, dead, 949 days
16.5
TCGA-24-1567-01A
0 years, female, white, stage:Stage IIIB, dead, 524 days
16.5
TCGA-13-0897-01A
0 years, female, white, stage:Stage IIIC, dead, 2182 days
16.2
TCGA-25-2409-01A
0 years, female, white, stage:Stage IV, dead, 821 days
16.1
TCGA-31-1944-01A
0 years, female, white, stage:Stage IIIC, alive, 1386 days
16.1
TCGA-13-1511-01A
0 years, female, asian, stage:Stage IV, dead, 1650 days
16.0
TCGA-36-1569-01A
0 years, female, white, stage:Stage IIIC, alive, 885 days
16.0
TCGA-31-1953-01A
0 years, female, asian, stage:Stage IIIC, alive, 204 days
15.8
TCGA-25-1313-01A
0 years, female, white, stage:Stage IV, dead, 820 days
15.7
TCGA-23-1116-01A
0 years, female, white, stage:Stage IIIC, dead, 592 days
15.7
TCGA-57-1585-01A
0 years, female, white, stage:Stage IIIC, dead, 53 days
15.7
TCGA-25-2401-01A
0 years, female, white, stage:Stage IIIC, dead, 90 days
15.6
TCGA-24-2035-01A
0 years, female, white, stage:Stage IIIC, dead, 857 days
15.2
TCGA-25-2400-01A
0 years, female, white, stage:Stage IIIC, dead, 1278 days
15.2
TCGA-61-1995-01A
0 years, female, white, stage:Stage IIIC, alive, 61 days
15.0
TCGA-13-0724-01A
0 years, female, white, stage:Stage IV, dead, 83 days
15.0
TCGA-04-1356-01A
0 years, female, white, stage:Stage IIC, dead, 1499 days
14.7
TCGA-61-2003-01A
0 years, female, white, stage:Stage IIIC, alive, 122 days
14.5
TCGA-61-1737-01A
0 years, female, white, stage:Stage IV, alive, 1364 days
14.2
TCGA-20-1687-01A
0 years, female, white, stage:Stage IV, alive, 81 days
13.9
TCGA-24-2261-01A
0 years, female, white, stage:Stage IIIC, dead, 24 days
13.9
TCGA-24-1434-01A
0 years, female, white, stage:Stage IIIC, dead, 568 days
13.9
TCGA-61-1918-01A
0 years, female, white, stage:Stage IV, dead, 479 days
13.8
TCGA-25-1320-01A
0 years, female, white, stage:Stage IIIC, dead, 1155 days
13.6
TCGA-24-1413-01A
0 years, female, white, stage:Stage IIIC, alive, 192 days
13.6
TCGA-29-1703-01A
0 years, female, black or african american, stage:Stage IIIC, dead, 1815 days
13.5
TCGA-25-1321-01A
0 years, female, white, stage:Stage IIIC, dead, 1033 days
13.4
TCGA-25-1322-01A
0 years, female, white, stage:Stage IV, dead, 91 days
13.3
TCGA-13-1403-01A
0 years, female, white, stage:Stage IIIC, dead, 2345 days
13.1
TCGA-24-1549-01A
0 years, female, white, stage:Stage IIIB, dead, 1721 days
12.8
TCGA-24-1422-01A
0 years, female, black or african american, stage:Stage IIIC, dead, 23 days
12.2
TCGA-25-1633-01A
0 years, female, white, stage:Stage IIIC, dead, 1891 days
12.2
TCGA-24-1604-01A
0 years, female, white, stage:Stage IIIC, dead, 2688 days
12.2
TCGA-24-2267-01A
0 years, female, white, stage:Stage IIB, dead, 1446 days
12.1
TCGA-57-1994-01A
0 years, female, white, stage:'--, alive, 761 days
12.1
TCGA-25-1870-01A
0 years, female, white, stage:Stage IIIC, dead, 455 days
12.0
TCGA-61-1910-01A
0 years, female, white, stage:Stage IIC, alive, 1127 days
11.9
TCGA-23-1111-01A
0 years, female, white, stage:Stage IIIC, alive, 98 days
11.9
TCGA-61-2109-01A
0 years, female, white, stage:Stage IIIC, dead, 629 days
11.8
TCGA-25-2392-01A
0 years, female, white, stage:Stage IV, dead, 31 days
11.7
TCGA-25-1315-01A
0 years, female, white, stage:Stage IIIC, dead, 1583 days
11.7
TCGA-25-1631-01A
0 years, female, white, stage:Stage IIIC, dead, 9 days
11.7
TCGA-24-2026-01A
0 years, female, white, stage:Stage IIIC, dead, 1059 days
11.7
TCGA-61-2008-01A
0 years, female, asian, stage:Stage IIC, alive, 932 days
11.6
TCGA-61-1911-01A
0 years, female, white, stage:Stage IIA, alive, 1293 days
11.6
TCGA-24-1435-01A
0 years, female, white, stage:Stage IIIC, dead, 1324 days
11.5
TCGA-30-1861-01A
0 years, female, white, stage:Stage IIIC, dead, 1058 days
11.4
TCGA-13-0883-01A
0 years, female, white, stage:Stage IIIC, dead, 2097 days
11.4
TCGA-13-0795-01A
0 years, female, white, stage:Stage IIIC, dead, 619 days
11.3
TCGA-23-2084-01A
0 years, female, white, stage:Stage IV, dead, 1516 days
11.3
TCGA-30-1892-01A
0 years, female, white, stage:Stage IIIC, dead, 1484 days
11.2
TCGA-24-1558-01A
0 years, female, white, stage:Stage IIIC, dead, 594 days
11.1
TCGA-25-1317-01A
0 years, female, white, stage:Stage IIIC, dead, 61 days
11.0
TCGA-31-1951-01A
0 years, female, white, stage:Stage IIIC, alive, 684 days
11.0
TCGA-24-2290-01A
0 years, female, white, stage:Stage IIIC, dead, 1102 days
11.0
TCGA-20-1683-01A
0 years, female, white, stage:Stage IIIC, alive, 772 days
11.0
TCGA-24-1603-01A
0 years, female, white, stage:Stage IIIB, dead, 2742 days
11.0
TCGA-13-2060-01A
0 years, female, white, stage:Stage IV, alive, 2369 days
10.9
TCGA-61-2111-01A
0 years, female, white, stage:Stage IV, alive, 3825 days
10.9
TCGA-29-1705-01A
0 years, female, white, stage:Stage IIIC, dead, 555 days
10.9
TCGA-61-1738-01A
0 years, female, black or african american, stage:Stage IIIC, dead, 1089 days
10.9
TCGA-61-2002-01A
0 years, female, white, stage:Stage IIIC, alive, 547 days
10.8
TCGA-09-0367-01A
0 years, female, native hawaiian or other pacific islander, stage:Stage IIIC, dead, 547 days
10.8
TCGA-24-1426-01A
0 years, female, white, stage:Stage IIIC, alive, 163 days
10.7
TCGA-24-2293-01A
0 years, female, white, stage:'--, dead, 506 days
10.7
TCGA-24-2297-01A
0 years, female, white, stage:Stage IIIC, dead, 1699 days
10.7
TCGA-13-1505-01A
0 years, female, white, stage:Stage IIIC, alive, 1998 days
10.7
TCGA-36-1576-01A
0 years, female, stage:Stage IIIC, alive, 915 days
10.7
TCGA-30-1718-01A
0 years, female, white, stage:Stage IIIC, dead, 1579 days
10.5
TCGA-61-2088-01A
0 years, female, white, stage:Stage IIIC, alive, 145 days
10.5
TCGA-30-1891-01A
0 years, female, white, stage:Stage IIIC, dead, 914 days
10.5
TCGA-13-0797-01A
0 years, female, white, stage:Stage IIIC, alive, 2121 days
10.5
TCGA-36-1574-01A
0 years, female, asian, stage:Stage IIIC, alive, 686 days
10.5
TCGA-29-1770-01A
0 years, female, white, stage:Stage IIIC, alive, 741 days
10.5
TCGA-25-1323-01A
0 years, female, white, stage:Stage IIIC, dead, 395 days
10.5
TCGA-13-0768-01A
0 years, female, white, stage:Stage IIIC, dead, 1784 days
10.4
TCGA-24-1552-01A
0 years, female, white, stage:Stage IIIC, dead, 1259 days
10.4
TCGA-31-1956-01A
0 years, female, white, stage:Stage IIIB, alive, 1342 days
10.4
TCGA-24-1930-01A
0 years, female, white, stage:Stage IIIC, dead, 2467 days
10.3
TCGA-24-1104-01A
0 years, female, white, stage:Stage IV, dead, 1933 days
10.3
TCGA-29-1783-01A
0 years, female, white, stage:Stage IIIC, alive, 220 days
10.2
TCGA-24-1418-01A
0 years, female, white, stage:Stage IIIC, alive, 243 days
10.2
TCGA-24-1474-01A
0 years, female, black or african american, stage:Stage IIIC, dead, 676 days
10.1
TCGA-25-1627-01A
0 years, female, white, stage:Stage IIIC, dead, 394 days
10.1
TCGA-10-0928-01A
0 years, female, white, stage:Stage IIIC, dead, 563 days
10.1
TCGA-57-1586-01A
0 years, female, white, stage:Stage IIIC, alive, 679 days
10.1
TCGA-24-1423-01A
0 years, female, white, stage:Stage IIIC, alive, 190 days
10.1
TCGA-61-1919-01A
0 years, female, white, stage:Stage IIIC, dead, 1161 days
10.0
TCGA-29-1778-01A
0 years, female, white, stage:Stage IIIC, alive, 454 days
10.0
TCGA-25-1312-01A
0 years, female, white, stage:Stage IV, dead, 31 days
10.0
TCGA-10-0937-01A
0 years, female, white, stage:Stage IIIC, dead, 608 days
9.9
TCGA-24-2280-01A
0 years, female, white, stage:Stage IIIC, alive, 2143 days
9.9
TCGA-25-2398-01A
0 years, female, white, stage:Stage IIIC, dead, 1369 days
9.8
TCGA-61-1725-01A
0 years, female, white, stage:Stage IIIC, alive, 956 days
9.8
TCGA-OY-A56Q-01A
0 years, female, black or african american, stage:Stage IIA, alive, 576 days
9.7
TCGA-23-1120-01A
0 years, female, white, stage:Stage IIIC, alive, 130 days
9.7
TCGA-30-1862-01A
0 years, female, white, stage:Stage IV, dead, 186 days
9.6
TCGA-61-2012-01A
0 years, female, white, stage:Stage IIC, alive, 932 days
9.5
TCGA-24-1464-01A
0 years, female, white, stage:Stage IIIC, dead, 379 days
9.5
TCGA-31-1950-01A
0 years, female, white, stage:Stage IIIC, alive, 571 days
9.4
TCGA-24-1844-01A
0 years, female, white, stage:Stage IIIC, alive, 113 days
9.4
TCGA-13-1485-01A
0 years, female, white, stage:Stage IV, dead, 629 days
9.4
TCGA-25-2396-01A
0 years, female, white, stage:Stage IIIC, dead, 92 days
9.4
TCGA-59-A5PD-01A
0 years, female, black or african american, stage:Stage IC, dead, 624 days
9.3
TCGA-13-1405-01A
0 years, female, white, stage:Stage IV, dead, 868 days
9.2
TCGA-24-2036-01A
0 years, female, white, stage:Stage IIIA, dead, 1947 days
9.2
TCGA-25-1626-01A
0 years, female, white, stage:Stage IIIC, dead, 518 days
9.1
TCGA-61-1741-01A
0 years, female, white, stage:Stage IIIB, dead, 1024 days
9.1
TCGA-29-1776-01A
0 years, female, black or african american, stage:Stage IIIC, alive, 360 days
9.0
TCGA-24-2271-01A
0 years, female, asian, stage:Stage IIIC, dead, 962 days
9.0
TCGA-04-1365-01A
0 years, female, white, stage:Stage IIIB, alive, 947 days
9.0
TCGA-25-1635-01A
0 years, female, white, stage:Stage IIIC, dead, 1583 days
9.0
TCGA-24-1550-01A
0 years, female, white, stage:Stage IIIC, dead, 1249 days
9.0
TCGA-30-1866-01A
0 years, female, white, stage:Stage IV, dead, 1114 days
9.0
TCGA-23-2077-01A
0 years, female, white, stage:Stage IIIC, alive, 3525 days
8.9
TCGA-23-1023-01A
0 years, female, white, stage:Stage IIIC, alive, 1233 days
8.9
TCGA-30-1853-01A
0 years, female, white, stage:Stage IIIC, dead, 1103 days
8.9
TCGA-24-1416-01A
0 years, female, white, stage:Stage IV, alive, 194 days
8.9
TCGA-24-2033-01A
0 years, female, white, stage:Stage IIIC, dead, 562 days
8.9
TCGA-09-0366-01A
0 years, female, white, stage:Stage IIIC, dead, 1757 days
8.8
TCGA-31-1959-01A
0 years, female, white, stage:Stage IV, alive, 67 days
8.8
TCGA-24-1553-01A
0 years, female, white, stage:Stage IIIB, dead, 1767 days
8.8
TCGA-24-1471-01A
0 years, female, white, stage:Stage IIIC, alive, 36 days
8.7
TCGA-29-1693-01A
0 years, female, white, stage:Stage IIIC, alive, 3096 days
8.7
TCGA-24-2023-01A
0 years, female, white, stage:Stage IIIA, dead, 1364 days
8.6
TCGA-24-0979-01A
0 years, female, white, stage:Stage IV, dead, 1264 days
8.5
TCGA-13-1404-01A
0 years, female, white, stage:Stage IIIC, alive, 2469 days
8.5
TCGA-04-1331-01A
0 years, female, white, stage:Stage IIIC, dead, 1336 days
8.5
TCGA-13-1411-01A
0 years, female, white, stage:Stage IIIC, dead, 531 days
8.4
TCGA-23-1123-01A
0 years, female, white, stage:Stage IIIC, dead, 1018 days
8.4
TCGA-09-2045-01A
0 years, female, asian, stage:Stage IV, dead, 1069 days
8.3
TCGA-24-1616-01A
0 years, female, white, stage:Stage IIIC, dead, 1163 days
8.2
TCGA-09-1662-01A
0 years, female, white, stage:Stage IV, dead, 2717 days
8.2
TCGA-29-1763-01A
0 years, female, black or african american, stage:Stage IIC, alive, 2032 days
8.2
TCGA-59-2350-01A
0 years, female, stage:Stage IV, dead, 679 days
8.2
TCGA-24-1424-01A
0 years, female, white, stage:Stage IIIC, alive, 183 days
8.1
TCGA-29-1695-01A
0 years, female, white, stage:Stage IIIC, dead, 1229 days
8.1
TCGA-24-1562-01A
0 years, female, white, stage:Stage IIIC, dead, 1384 days
8.1
TCGA-29-1785-01A
0 years, female, white, stage:Stage IIIC, dead, 1104 days
8.1
TCGA-04-1361-01A
0 years, female, white, stage:Stage IIIB, alive, 989 days
8.0
TCGA-13-0714-01A
0 years, female, white, stage:Stage IV, dead, 189 days
8.0
TCGA-29-1766-01A
0 years, female, white, stage:Stage IIIC, dead, 1199 days
8.0
TCGA-36-1577-01A
0 years, female, asian, stage:Stage IIC, alive, 783 days
7.9
TCGA-29-1690-01A
0 years, female, white, stage:Stage IIIC, dead, 1448 days
7.7
TCGA-61-2092-01A
0 years, female, white, stage:Stage IIIC, alive, 1573 days
7.7
TCGA-24-0982-01A
0 years, female, white, stage:Stage IIIC, dead, 679 days
7.7
TCGA-09-2051-01A
0 years, female, white, stage:Stage IIIC, alive, 1919 days
7.5
TCGA-13-0765-01A
0 years, female, white, stage:Stage IIIC, dead, 1389 days
7.5
TCGA-24-2027-01A
0 years, female, white, stage:Stage IV, dead, 3337 days
7.4
TCGA-24-1419-01A
0 years, female, white, stage:Stage IIIC, alive, 239 days
7.4
TCGA-24-1842-01A
0 years, female, white, stage:Stage IIIC, alive, 253 days
7.3
TCGA-13-1512-01A
0 years, female, white, stage:Stage IIIC, alive, 442 days
7.3
TCGA-13-1507-01A
0 years, female, white, stage:Stage IIIC, dead, 1993 days
7.3
TCGA-23-1809-01A
0 years, female, white, stage:Stage IIC, alive, 16 days
7.3
TCGA-13-0720-01A
0 years, female, white, stage:Stage IIIC, dead, 1355 days
7.3
TCGA-24-2288-01A
0 years, female, white, stage:Stage IIIC, dead, 25 days
7.1
TCGA-61-2098-01A
0 years, female, white, stage:Stage IIIC, alive, 1993 days
7.1
TCGA-61-2000-01A
0 years, female, white, stage:Stage IIIC, alive, 441 days
7.1
TCGA-25-1328-01A
0 years, female, white, stage:Stage IIIC, dead, 2009 days
7.1
TCGA-24-2281-01A
0 years, female, white, stage:Stage IIA, alive, 1357 days
7.1
TCGA-61-1998-01A
0 years, female, white, stage:Stage IIIC, alive, 168 days
7.0
TCGA-24-1551-01A
0 years, female, white, stage:Stage IIIC, dead, 1579 days
7.0
TCGA-13-1506-01A
0 years, female, white, stage:Stage IIIC, dead, 1039 days
7.0
TCGA-09-1666-01A
0 years, female, white, stage:Stage IIIC, alive, 1752 days
7.0
TCGA-61-1914-01A
0 years, female, stage:Stage IIIC, alive, 1722 days
7.0
TCGA-61-1721-01A
0 years, female, white, stage:Stage IV, alive, 338 days
6.9
TCGA-13-0800-01A
0 years, female, white, stage:Stage IIIC, alive, 2661 days
6.9
TCGA-30-1714-01A
0 years, female, white, stage:Stage IV, dead, 1158 days
6.9
TCGA-36-1581-01A
0 years, female, white, stage:Stage IIC, alive, 751 days
6.9
TCGA-59-2363-01A
0 years, female, asian, stage:Stage IIIA, alive, 165 days
6.9
TCGA-29-1697-01A
0 years, female, white, stage:Stage IIIC, dead, 949 days
6.9
TCGA-59-2352-01A
0 years, female, white, stage:Stage IIIC, dead, 286 days
6.8
TCGA-04-1364-01A
0 years, female, white, stage:Stage IIIC, dead, 1024 days
6.8
TCGA-20-1686-01A
0 years, female, white, stage:Stage IIIC, alive, 89 days
6.8
TCGA-29-1688-01A
0 years, female, white, stage:Stage IIIC, dead, 2400 days
6.8
TCGA-23-1109-01A
0 years, female, white, stage:Stage IIIC, dead, 1562 days
6.7
TCGA-29-2425-01A
0 years, female, white, stage:Stage IIIC, alive, 1977 days
6.7
TCGA-57-1582-01A
0 years, female, white, stage:Stage IIIC, dead, 731 days
6.7
TCGA-13-1483-01A
0 years, female, white, stage:Stage IIIC, dead, 895 days
6.6
TCGA-24-1928-01A
0 years, female, white, stage:Stage IIIC, dead, 336 days
6.6
TCGA-24-1924-01A
0 years, female, white, stage:Stage IIIC, dead, 919 days
6.6
TCGA-61-2102-01A
0 years, female, white, stage:Stage IIIC, dead, 197 days
6.6
TCGA-24-1430-01A
0 years, female, white, stage:Stage IIIC, dead, 863 days
6.6
TCGA-30-1860-01A
0 years, female, white, stage:Stage IIIC, dead, 1366 days
6.6
TCGA-36-1580-01A
0 years, female, stage:Stage IIIC, dead, 737 days
6.6
TCGA-09-1673-01A
0 years, female, white, stage:Stage IV, alive, 92 days
6.5
TCGA-13-0886-01A
0 years, female, white, stage:Stage IIIC, alive, 4665 days
6.5
TCGA-13-1499-01A
0 years, female, white, stage:Stage IIIC, alive, 3500 days
6.5
TCGA-61-1907-01A
0 years, female, white, stage:Stage IIIC, alive, 952 days
6.5
TCGA-13-A5FT-01A
0 years, female, black or african american, stage:Stage IIIC, alive, 2143 days
6.3
TCGA-23-2078-01A
0 years, female, white, stage:Stage IIIC, alive, 2661 days
6.3
TCGA-13-1496-01A
0 years, female, white, stage:Stage IIIC, dead, 129 days
6.3
TCGA-09-2054-01A
0 years, female, black or african american, stage:Stage IIIC, dead, 637 days
6.3
TCGA-13-0924-01A
0 years, female, white, stage:Stage IV, alive, 2614 days
6.3
TCGA-24-2020-01A
0 years, female, white, stage:Stage IIIC, dead, 4624 days
6.2
TCGA-23-1110-01A
0 years, female, white, stage:Stage IIIC, alive, 1658 days
6.2
TCGA-25-1630-01A
0 years, female, white, stage:Stage IIIC, dead, 1162 days
6.2
TCGA-23-1119-01A
0 years, female, white, stage:Stage IIIC, alive, 3953 days
6.1
TCGA-09-0364-01A
0 years, female, white, stage:Stage IIC, dead, 887 days
6.1
TCGA-24-2024-01A
0 years, female, black or african american, stage:Stage IIIC, dead, 1769 days
6.1
TCGA-04-1343-01A
0 years, female, white, stage:Stage IV, dead, 361 days
6.1
TCGA-29-1784-01A
0 years, female, white, stage:Stage IIIC, alive, 163 days
6.0
TCGA-23-1122-01A
0 years, female, white, stage:Stage IIIC, dead, 1189 days
6.0
TCGA-25-1319-01A
0 years, female, white, stage:Stage IIIC, dead, 1977 days
6.0
TCGA-04-1655-01A
0 years, female, white, stage:Stage IIIB, dead, 1380 days
6.0
TCGA-24-1467-01A
0 years, female, white, stage:Stage IIIC, dead, 3224 days
6.0
TCGA-WR-A838-01A
0 years, female, black or african american, stage:Stage IIIC, dead, 304 days
5.9
TCGA-29-2414-01A
0 years, female, white, stage:Stage IIIC, dead, 2621 days
5.8
TCGA-20-0987-01A
0 years, female, white, stage:Stage IIIC, dead, 701 days
5.8
TCGA-24-1850-01A
0 years, female, white, stage:Stage IIIC, alive, 168 days
5.7
TCGA-24-1546-01A
0 years, female, white, stage:Stage IIIC, dead, 1955 days
5.7
TCGA-25-1316-01A
0 years, female, white, stage:Stage IIIC, dead, 1279 days
5.7
TCGA-61-2101-01A
0 years, female, white, stage:Stage IIIC, dead, 1688 days
5.6
TCGA-29-1769-01A
0 years, female, white, stage:Stage IIIC, alive, 699 days
5.6
TCGA-04-1332-01A
0 years, female, white, stage:Stage IIIC, dead, 1247 days
5.6
TCGA-04-1530-01A
0 years, female, white, stage:Stage IIIC, dead, 3622 days
5.4
TCGA-13-0725-01A
0 years, female, white, stage:Stage IIIC, dead, 377 days
5.4
TCGA-04-1514-01A
0 years, female, white, stage:Stage IIIA, dead, 1720 days
5.3
TCGA-04-1651-01A
0 years, female, white, stage:Stage IIIC, dead, 1102 days
5.3
TCGA-36-1571-01A
0 years, female, white, stage:Stage IIIB, dead, 695 days
5.3
TCGA-13-1488-01A
0 years, female, white, stage:Stage IV, dead, 2154 days
5.2
TCGA-23-1030-01A
0 years, female, white, stage:Stage IIIC, alive, 886 days
5.2
TCGA-29-1781-01A
0 years, female, white, stage:Stage IIIC, alive, 255 days
5.1
TCGA-04-1542-01A
0 years, female, white, stage:Stage IIIB, dead, 2561 days
5.1
TCGA-61-1733-01A
0 years, female, white, stage:Stage IIIC, alive, 967 days
5.1
TCGA-24-1560-01A
0 years, female, white, stage:Stage IIIC, dead, 1341 days
5.0
TCGA-20-1682-01A
0 years, female, white, stage:Stage IIIC, alive, 837 days
5.0
TCGA-13-0730-01A
0 years, female, white, stage:Stage IIIC, dead, 542 days
4.9
TCGA-24-2038-01A
0 years, female, white, stage:Stage IIIA, dead, 1354 days
4.9
TCGA-13-1408-01A
0 years, female, white, stage:Stage IIIC, dead, 1680 days
4.9
TCGA-24-1428-01A
0 years, female, white, stage:Stage IIIC, alive, 529 days
4.9
TCGA-61-2009-01A
0 years, female, white, stage:Stage IIIC, alive, 1212 days
4.8
TCGA-13-0911-01A
0 years, female, white, stage:Stage IV, dead, 1355 days
4.8
TCGA-24-1469-01A
0 years, female, white, stage:Stage IIIC, alive, 277 days
4.7
TCGA-36-1568-01A
0 years, female, stage:Stage IIIC, alive, 875 days
4.7
TCGA-25-1632-01A
0 years, female, white, stage:Stage IV, dead, 1799 days
4.7
TCGA-24-1923-01A
0 years, female, white, stage:Stage IIIC, dead, 690 days
4.6
TCGA-13-1409-01A
0 years, female, white, stage:Stage IIIC, dead, 1742 days
4.6
TCGA-04-1338-01A
0 years, female, white, stage:Stage IIIC, alive, 1418 days
4.6
TCGA-57-1583-01A
0 years, female, black or african american, stage:Stage IIIC, dead, 346 days
4.5
TCGA-24-0968-01A
0 years, female, white, stage:Stage IIIC, dead, 598 days
4.5
TCGA-29-1774-01A
0 years, female, white, stage:Stage IIIC, alive, 527 days
4.5
TCGA-25-1634-01A
0 years, female, white, stage:Stage IIIC, dead, 1091 days
4.5
TCGA-29-2427-01A
0 years, female, white, stage:Stage IIIC, alive, 1900 days
4.5
TCGA-10-0927-01A
0 years, female, stage:Stage IIIC, dead, 2490 days
4.4
TCGA-13-0762-01A
0 years, female, white, stage:Stage IIIC, alive, 3400 days
4.3
TCGA-24-1103-01A
0 years, female, black or african american, stage:Stage IIIC, dead, 1646 days
4.3
TCGA-24-1843-01A
0 years, female, white, stage:Stage IIIC, alive, 106 days
4.3
TCGA-13-1487-01A
0 years, female, white, stage:Stage IV, dead, 681 days
4.2
TCGA-13-1492-01A
0 years, female, white, stage:Stage IIIC, dead, 3819 days
4.2
TCGA-13-0891-01A
0 years, female, white, stage:Stage IV, dead, 3128 days
4.2
TCGA-23-1028-01A
0 years, female, white, stage:Stage IIIC, alive, 1503 days
4.2
TCGA-24-1544-01A
0 years, female, black or african american, stage:Stage IIIC, dead, 820 days
4.1
TCGA-13-1501-01A
0 years, female, white, stage:Stage IV, dead, 1314 days
4.1
TCGA-13-0923-01A
0 years, female, white, stage:Stage IIIC, alive, 2547 days
4.0
TCGA-29-1691-01A
0 years, female, white, stage:Stage IIIC, dead, 1470 days
4.0
TCGA-29-1768-01A
0 years, female, white, stage:Stage IV, dead, 952 days
4.0
TCGA-20-0991-01A
0 years, female, white, stage:Stage IIB, alive, 797 days
3.9
TCGA-13-0906-01A
0 years, female, white, stage:Stage IIIC, alive, 3619 days
3.9
TCGA-29-1762-01A
0 years, female, white, stage:Stage IV, dead, 2634 days
3.9
TCGA-13-1495-01A
0 years, female, white, stage:Stage IIIC, dead, 2749 days
3.9
TCGA-04-1519-01A
0 years, female, stage:Stage IIIC, alive, 24 days
3.9
TCGA-13-1510-01A
0 years, female, white, stage:Stage IIIC, dead, 1359 days
3.8
TCGA-09-1669-01A
0 years, female, white, stage:Stage IIIA, alive, 928 days
3.8
TCGA-23-1113-01A
0 years, female, white, stage:Stage IV, dead, 949 days
3.7
TCGA-04-1536-01A
0 years, female, black or african american, stage:Stage IV, dead, 885 days
3.7
TCGA-10-0938-01A
0 years, female, white, stage:Stage IIIC, dead, 636 days
3.7
TCGA-24-1565-01A
0 years, female, white, stage:Stage IIIC, dead, 312 days
3.7
TCGA-25-2393-01A
0 years, female, white, stage:Stage IIIC, dead, 1157 days
3.7
TCGA-24-1431-01A
0 years, female, white, stage:Stage IIIC, dead, 583 days
3.6
TCGA-13-1498-01A
0 years, female, white, stage:Stage IIIC, dead, 2012 days
3.5
TCGA-29-1761-01A
0 years, female, asian, stage:Stage IIIC, dead, 528 days
3.5
TCGA-13-0804-01A
0 years, female, white, stage:Stage IIIC, dead, 1073 days
3.5
TCGA-59-2351-01A
0 years, female, white, stage:Stage IIIC, alive, 3532 days
3.5
TCGA-59-2348-01A
0 years, female, white, stage:Stage IIIC, alive, 5481 days
3.4
TCGA-61-2110-01A
0 years, female, white, stage:Stage IIIC, dead, 1354 days
3.4
TCGA-13-0885-01A
0 years, female, white, stage:Stage IIIC, alive, 3388 days
3.2
TCGA-13-1489-01A
0 years, female, white, stage:Stage IIIC, dead, 2553 days
3.2
TCGA-25-1877-01A
0 years, female, white, stage:Stage IIIC, dead, 730 days
3.2
TCGA-04-1350-01A
0 years, female, white, stage:Stage IIIC, dead, 1946 days
3.0
TCGA-13-0727-01A
0 years, female, white, stage:Stage IIIC, dead, 462 days
3.0
TCGA-23-1027-01A
0 years, female, white, stage:Stage IIIC, dead, 976 days
3.0
TCGA-13-0887-01A
0 years, female, white, stage:Stage IIIC, dead, 2028 days
3.0
TCGA-04-1341-01A
0 years, female, white, stage:'--, alive, 33 days
2.9
TCGA-13-1497-01A
0 years, female, white, stage:Stage IIIC, alive, 3871 days
2.9
TCGA-29-1701-01A
0 years, female, white, stage:Stage IIIC, dead, 515 days
2.8
TCGA-61-1900-01A
0 years, female, black or african american, stage:Stage IIIB, alive, 176 days
2.8
TCGA-13-1509-01A
0 years, female, white, stage:Stage IV, alive, 2438 days
2.7
TCGA-24-1845-01A
0 years, female, white, stage:Stage IIIC, alive, 116 days
2.7
TCGA-10-0931-01A
0 years, female, white, stage:Stage IIIC, dead, 1000 days
2.7
TCGA-23-1118-01A
0 years, female, white, stage:Stage IIIC, alive, 2616 days
2.7
TCGA-23-1022-01A
0 years, female, white, stage:Stage IIIC, dead, 1511 days
2.6
TCGA-29-1777-01A
0 years, female, white, stage:Stage IIIC, alive, 374 days
2.6
TCGA-10-0933-01A
0 years, female, white, stage:Stage IIIC, dead, 446 days
2.6
TCGA-13-0888-01A
0 years, female, white, stage:Stage IIIC, dead, 2811 days
2.5
TCGA-23-1024-01A
0 years, female, white, stage:Stage IV, alive, 468 days
2.4
TCGA-13-1407-01A
0 years, female, white, stage:Stage IIIC, alive, 2534 days
2.2
TCGA-04-1347-01A
0 years, female, white, stage:Stage IV, alive, 1919 days
2.1
TCGA-24-0966-01A
0 years, female, black or african american, stage:Stage IIIC, alive, 232 days
2.1
TCGA-23-1107-01A
0 years, female, white, stage:Stage IV, dead, 9 days
2.0
TCGA-09-0369-01A
0 years, female, white, stage:Stage IIIC, dead, 1082 days
2.0
TCGA-13-1477-01A
0 years, female, white, stage:Stage IV, dead, 1662 days
2.0
TCGA-29-2428-01A
0 years, female, white, stage:Stage IIIC, alive, 1372 days
1.9
TCGA-13-0916-01A
0 years, female, white, stage:Stage IIIC, alive, 1785 days
1.7
TCGA-13-0920-01A
0 years, female, white, stage:Stage IIIC, dead, 1484 days
1.4
TCGA-13-0766-01A
0 years, female, white, stage:Stage IIIC, dead, 1725 days
1.4
TCGA-09-2048-01A
0 years, female, white, stage:Stage IIIC, dead, 138 days
The Survival Scatter plot shows the clinical status (i.e. dead or alive) for all individuals in the patient cohort, based on the same data that underlies the corresponding Kaplan-Meier plots. Patients that are alive at last time for follow-up are shown in blue and patients who have died during the study are shown in red.
The x-axis shows the expression levels (FPKM) of the investigated gene in the tumor tissue at the time of diagnosis. The y-axis shows the follow-up time after diagnosis (years). Both axes are complimented with kernel density curves demonstrating the data density over the axes. The top density plot shows the expression levels (FPKM) distribution among dead (red) and alive patients (blue). The right density plot shows the data density of the survived years of dead patients with high and low expression levels respectively, stratified using the cutoff indicated by the vertical dashed line through the Survival Scatter plot. This cutoff is automatically defined based on the FPKM cutoff that minimizes the p-score. The cutoff can be changed by dragging the vertical line or by entering a cutoff value in the square labeled "Current cut-off".
Under the Survival Scatter plot the p-score landscape (black curve; left axis) is shown together with dead median separation (red curve; right axis). Dead median separation is the difference in median mRNA expression between patients who have died with high and low expression, respectively. It is calculated as follows: median FPKM expression of dead patients with high expression - median FPKM expression of dead patients with low expression. This is intended to aid the user in visually exploring custom cutoffs and the associated p-scores and dead median separation.
Individual patient data is displayed and can be filtered by clicking on one or more of the category buttons on the top of the page. Categories describing expression level and patient information include: high, low, alive, dead, female, male and tumor stages. The scale of the x-axis can be toggled between linear and log-scale by clicking on the "x log" button. Mouse-over function shows TCGA ID, patient information and mRNA expression (FPKM) for each patient.
& Survival analysisi
Kaplan-Meier plots summarize results from analysis of correlation between mRNA expression level and patient survival. Patients were divided based on level of expression into one of the two groups "low" (under cut off) or "high" (over cut off). X-axis shows time for survival (years) and y-axis shows the probability of survival, where 1.0 corresponds to 100 percent.
PDP1 is not prognostic in Ovary Serous Cystadenocarcinoma (validation)
Stage:
Survival analysis
Current cut offi
Current cut-off shows the cut-off (FPKM) currently selected. It may be changed manually. When the current cut-off is changed, the vertical dashed line indicating cut-off, the interactive survival scatter plot and the Kaplan-Meier curve will be automatically adjusted to show results accordingly.
:
Best expression cut offi
Based on the FPKM value of each gene, patients were classified into two groups and association between prognosis (survival) and gene expression (FPKM) was examined. The best expression cut-off refers the FPKM value that yields maximal difference with regard to survival between the two groups at the lowest log-rank P-value. Best expression cut-off was selected based on survival analysis .
When clicking on this number, the vertical dashed line indicating cut-off, the interactive survival plot, and the Kaplan-Meier curve will be adjusted to show results based on the best expression cut-off.
Median expression refers to the median FPKM value calculated based on the gene expression (FPKM) data from all patients in this dataset. When clicking on this number, the vertical dashed line indicating cut-off, the interactive survival plot, and the Kaplan-Meier curve will be adjusted to show results based on the median expression.
Median follow up time refers to the median time (years) after diagnosis with this type of cancer, based on clinical data from all patients in this dataset.
: N/A
P scorei
Log-rank P value for Kaplan-Meier plot showing results from analysis of correlation between mRNA expression level and patient survival.
N/A
5-year survival highi
5-year survival for patients with higher expression than the expression cutoff.
For melanoma and glioma, 3-year survival is shown.
N/A
5-year survival lowi
5-year survival for patients with lower expression than the expression cutoff.
For melanoma and glioma, 3-year survival is shown.
N/A
TCGA RNA samplesi
RNA-seq data is reported as average FPKM (number Fragments Per Kilobase of exon per Million reads), generated by the The Cancer Genome Atlas (TCGA) .
Normal distribution across the dataset is visualized with box plots, shown as median and 25th and 75th percentiles. Points are displayed as outliers if they are above or below 1.5 times the interquartile range. FPKM values of the individual samples are presented next to the box plot.
Average TPM
10.8
Number of samples
81
Samples
Sample
Description
TPM
DO46374
0 years, female, NA, stage:III, dead, 1409 days
35.8
DO46327
0 years, female, NA, stage:III, dead, 184 days
35.2
DO46340
0 years, female, NA, stage:III, dead, 616 days
32.1
DO46325
0 years, female, NA, stage:III, dead, 477 days
26.6
DO46346
0 years, female, NA, stage:III, dead, 1187 days
24.8
DO46396
0 years, female, NA, stage:III, dead, 583 days
24.7
DO46571
0 years, female, NA, stage:III, dead, 243 days
22.7
DO46398
0 years, female, NA, stage:III, alive, 437 days
21.6
DO46400
0 years, female, NA, stage:III, dead, 719 days
19.9
DO46606
0 years, female, NA, stage:III, alive, 804 days
19.4
DO46344
0 years, female, NA, stage:III, dead, 642 days
19.0
DO46508
0 years, female, NA, stage:III, dead, 2101 days
18.0
DO46330
0 years, female, NA, stage:III, dead, 684 days
16.6
DO46602
0 years, female, NA, stage:III, dead, 205 days
16.2
DO46597
0 years, female, NA, stage:III, dead, 393 days
15.9
DO46408
0 years, female, NA, stage:III, dead, 489 days
15.8
DO46518
0 years, female, NA, stage:III, alive, 2960 days
14.8
DO46348
0 years, female, NA, stage:IV, dead, 287 days
14.5
DO46354
0 years, female, NA, stage:III, dead, 843 days
14.5
DO46448
0 years, female, NA, stage:III, dead, 654 days
14.3
DO46404
0 years, female, NA, stage:III, dead, 690 days
14.1
DO46386
0 years, female, NA, stage:III, dead, 1162 days
13.7
DO46380
0 years, female, NA, stage:III, dead, 1423 days
13.6
DO46336
0 years, female, NA, stage:IV, dead, 664 days
13.1
DO46428
0 years, female, NA, stage:IV, alive, 2644 days
13.1
DO46334
0 years, female, NA, stage:III, dead, 496 days
13.1
DO46568
0 years, female, NA, stage:III, dead, 320 days
12.3
DO46350
0 years, female, NA, stage:III, dead, 886 days
11.9
DO46546
0 years, female, NA, stage:III, dead, 1889 days
11.9
DO46560
0 years, female, NA, stage:IV, dead, 286 days
11.8
DO46382
0 years, female, NA, stage:IV, dead, 311 days
11.3
DO46326
0 years, female, NA, stage:III, dead, 701 days
10.8
DO46443
0 years, female, NA, stage:III, dead, 2464 days
10.6
DO46402
0 years, female, NA, stage:III, dead, 511 days
10.5
DO46438
0 years, female, NA, stage:IV, alive, 2227 days
10.4
DO46332
0 years, female, NA, stage:III, dead, 689 days
10.3
DO46328
0 years, female, NA, stage:III, dead, 972 days
9.8
DO46338
0 years, female, NA, stage:III, dead, 596 days
9.8
DO46372
0 years, female, NA, stage:III, dead, 1326 days
9.5
DO46388
0 years, female, NA, stage:III, dead, 413 days
9.3
DO46368
0 years, female, NA, stage:III, dead, 2879 days
9.3
DO46432
0 years, female, NA, stage:III, alive, 2218 days
9.3
DO46436
0 years, female, NA, stage:III, alive, 3193 days
8.8
DO46360
0 years, female, NA, stage:IV, dead, 1759 days
8.8
DO46394
0 years, female, NA, stage:IV, dead, 1039 days
8.6
DO46566
0 years, female, NA, stage:III, dead, 673 days
8.6
DO46533
0 years, female, NA, stage:III, alive, 3667 days
8.4
DO46493
0 years, female, NA, stage:IV, alive, 839 days
8.4
DO46378
0 years, female, NA, stage:III, alive, 843 days
8.0
DO46513
0 years, female, NA, stage:IV, dead, 1883 days
7.8
DO46538
0 years, female, NA, stage:III, dead, 1527 days
7.7
DO46384
0 years, female, NA, stage:III, dead, 614 days
7.4
DO46588
0 years, female, NA, stage:III, dead, 438 days
6.8
DO46358
0 years, female, NA, stage:III, dead, 423 days
6.6
DO46551
0 years, female, NA, stage:III, dead, 1055 days
6.5
DO46523
0 years, female, NA, stage:IV, alive, 1873 days
6.5
DO46581
0 years, female, NA, stage:III, dead, 408 days
6.4
DO46392
0 years, female, NA, stage:III, dead, 628 days
6.2
DO46390
0 years, female, NA, stage:III, dead, 374 days
6.2
DO46352
0 years, female, NA, stage:III, dead, 677 days
5.8
DO46364
0 years, female, NA, stage:III, dead, 806 days
5.5
DO46329
0 years, female, NA, stage:III, dead, 1699 days
5.4
DO46528
0 years, female, NA, stage:III, alive, 6139 days
5.3
DO46412
0 years, female, NA, stage:III, dead, 597 days
5.2
DO46586
0 years, female, NA, stage:III, dead, 1019 days
4.8
DO46376
0 years, female, NA, stage:III, dead, 1430 days
4.6
DO46362
0 years, female, NA, stage:III, dead, 1639 days
4.4
DO46331
0 years, female, NA, stage:III, dead, 612 days
4.1
DO46576
0 years, female, NA, stage:III, alive, 133 days
4.1
DO46356
0 years, female, NA, stage:III, dead, 911 days
4.0
DO46370
0 years, female, NA, stage:III, dead, 1727 days
3.9
DO46468
0 years, female, NA, stage:III, alive, 2776 days
3.7
DO46611
0 years, female, NA, stage:III, dead, 734 days
3.6
DO46591
0 years, female, NA, stage:III, dead, 195 days
3.5
DO46561
0 years, female, NA, stage:III, dead, 195 days
2.8
DO46458
0 years, female, NA, stage:IV, alive, 3787 days
2.8
DO46463
0 years, female, NA, stage:III, dead, 2451 days
2.7
DO46366
0 years, female, NA, stage:III, dead, 2054 days
2.1
DO46453
0 years, female, NA, stage:III, dead, 3294 days
1.9
DO46333
0 years, female, NA, stage:III, dead, 359 days
1.6
DO46342
0 years, female, NA, stage:III, dead, 1398 days
1.4
Show allShow less
OVARY SEROUS CYSTADENOCARCINOMA - Protein relative expression (CPTAC)
Number of samples
108
Samples
Sample ID
Sample type
nRPX
0745488e-0bfb-4d1f-8228-dedf76_D1_D2
Normal
0.8
a3a26070-fb84-406a-8280-d555e6_D2
Normal
0.7
092af714-b97a-457c-b0e9-8c20e8_D2
Normal
0.6
6319b36b-533c-4e86-8e12-80552e_D3
Tumor
0.6
e6850782-fd2a-4c53-b682-1852fe_D2
Tumor
0.5
e23eb014-69c1-460a-b9d4-9786c8_D2
Normal
0.4
994f9b8e-46cb-413f-8ec8-2c2fed_D2
Normal
0.4
1772e913-f62e-446a-8cf3-720348_D2
Tumor
0.3
7c7ce2d7-6c8a-424e-8e6c-d14ad1_D2
Tumor
0.3
8234f8ea-bdbd-45b0-bd0b-16f1e7_D2
Tumor
0.3
fbb41c94-aabd-49cc-90b2-882c3e_D2
Tumor
0.3
bd266bdd-12e4-42cb-9c49-911bfc_D2
Tumor
0.3
256ac9f5-1e19-44b4-92fb-fef3fc_D2
Tumor
0.2
a65d8e76-640f-4341-a561-afbb57_D2
Normal
0.2
49bd51fe-48a1-4828-b66e-b30c38_D2
Tumor
0.2
927f0958-db5a-4bc5-92b7-2a3695_D2
Tumor
0.2
e7b656bf-3c34-4ba1-bdf3-c7eefe_D2
Tumor
0.2
61f76fe6-a1c6-41b8-bdc2-2f9209_D2
Normal
0.2
74a45e5a-a35a-4c60-a4b4-f3f5ea_D2
Tumor
0.2
7edfd606-4bee-4529-9fec-1ca7f0_D2
Normal
0.2
285fed94-1495-448e-879b-b55de9_D2
Tumor
0.1
21efd60f-6a31-4b98-9477-16a905_D2
Normal
0.1
1abbcb28-f221-4cd4-8c01-37b9bb_D1_D2
Normal
0.1
9a7a86d3-bbf2-4d36-941d-c75c03_D1_D2
Tumor
0.1
2b4ce90c-8036-4207-ac3e-54a76f_D2
Tumor
0.1
b9c1f22e-61f7-45ed-b3b4-5094c7_D2
Normal
0.1
6e209757-a7f4-45af-b5f3-2ebc02_D2
Normal
0.1
eb3f3494-7057-4afe-b212-e6e9a3_D2
Tumor
0.1
05387aad-2a1f-42c2-8d6f-950598_D3
Tumor
0.1
08296da7-70ea-44df-8646-09f2cc_D2
Tumor
0.1
1556af7e-c2ae-4fce-9aae-87c459_D1_D2
Normal
0.1
50997c44-1c8b-4d34-b535-4a6cc2_D2
Tumor
0.1
3d3e1888-d67e-4c69-ba83-112d0f_D2
Tumor
0.1
8ed739dd-ae0f-4881-971a-db3cf4_D1_D2
Normal
0.1
41d0619e-b299-42e2-ac32-29e784_D2
Tumor
0.1
a8853382-b726-4ce8-98d5-ca89df_D2
Tumor
0.1
1c9145ad-1981-4871-aa7e-8b11de_D2
Tumor
0.1
42d860a3-8a0c-4c44-a09a-9ad8cf_D2
Tumor
0.1
46c73531-f531-4ec3-97fe-b39d9d_D2
Tumor
0.0
8d78194e-fbef-4819-a7b5-b73ae9_D2
Tumor
0.0
52c064a7-78d9-4a1a-85b4-27c6d1_D2
Tumor
0.0
35a345a4-e954-4c81-ae3f-7797cd_D2
Tumor
0.0
627e6e36-3dca-4ee5-9755-6f3510_D2
Tumor
0.0
c17b0ff9-9057-4848-a0cc-abb25f_D2
Tumor
0.0
3dcf8b3c-c0c5-4dfa-9543-5d30fb_D2
Tumor
0.0
62f5840e-6cd7-4200-b651-645e53_D2
Tumor
0.0
8e17b45e-6a06-4e4e-913d-7b1edb_D2
Tumor
0.0
5ea22f5e-307b-491d-801f-8b7fa6_D2
Tumor
0.0
340a3769-3031-41ae-bb08-a2f696_D2
Normal
0.0
e3ebe010-cd31-4b5d-8fcb-b7103b_D2
Tumor
0.0
ce1e5dfc-2ef1-4633-af93-5ea4d9_D2
Tumor
0.0
558333b0-ea23-4303-9e3c-4932b1_D2
Tumor
0.0
9e0d47e0-f633-468b-b82b-4d752d_D2
Tumor
0.0
b22659b9-e12c-4725-a7db-a833de_D1_D2
Normal
0.0
1db5574d-aca7-403c-8100-6e705f_D2
Normal
0.0
3a380577-c134-47ba-a1ce-988d7c_D2
Tumor
0.0
51a4ce2f-4166-4c6b-a7e0-942d0a_D2
Tumor
0.0
af95e2c6-25c4-4ab8-bf06-3e15ff_D2
Tumor
0.0
31c15e30-21d4-4843-bd4a-9cd0d8_D2
Normal
-0.1
2433b136-fc7b-4cea-b958-bc6efb_D2
Tumor
-0.1
fe83e13f-9754-403b-8f74-d6caf8_D2
Tumor
-0.1
2563cb02-d58a-4286-8634-7502cd_D2
Tumor
-0.1
9c8e78bf-b03e-4ba0-9909-5ff070_D2
Tumor
-0.1
1de8d3d8-fc0e-4be0-8aa7-127c7b_D2
Tumor
-0.1
cfd76f9a-ce60-4ec7-8e6b-a8fc31_D3
Tumor
-0.1
2115808b-6a0d-49bc-a8d7-b83bde_D2
Tumor
-0.1
2f901c90-617e-46da-9fac-d68369_D2
Tumor
-0.1
27f3ca2d-a86f-479d-8e7e-5307c7_D2
Tumor
-0.1
10c2d629-0287-4511-ac25-f29031_D2
Tumor
-0.1
0c87932d-b6fd-4eb5-b86a-a34d07_D2
Tumor
-0.1
2ed8beb2-bc63-4bad-b5fe-1916a0_D2
Tumor
-0.1
d4791079-c826-4fc7-9d9b-ee20ba_D2
Tumor
-0.1
3fbf076a-824b-4eac-b6dc-bf5e59_D2
Normal
-0.1
efc971f8-54c5-4531-a792-705ecf_D2
Tumor
-0.1
161317f3-1a39-438e-af45-cd2502_D2
Tumor
-0.1
2dc28da8-7ff1-4b9b-b5bd-17cc25_D2
Tumor
-0.1
79b60f32-6cca-4cb6-9a1e-22a3ac_D2
Tumor
-0.1
4ccb249a-6722-491e-97e9-e3b4e7_D2
Tumor
-0.2
7069e990-4a4e-4984-a66d-4d835a_D2
Tumor
-0.2
5c3971ee-87c7-4dff-b66e-f18892_D2
Tumor
-0.2
eb0a53df-7620-4024-8d2d-051142_D2
Tumor
-0.2
6530147a-efe9-4df6-ac2f-03ece3_D2
Tumor
-0.2
7d953d1d-84b6-4ecd-b1d7-1ed865_D2
Tumor
-0.2
1a10c200-3895-4648-b951-94f99f_D2
Tumor
-0.2
a583d3ff-8165-43e9-b764-23b7ef_D1_D2
Normal
-0.2
3946a96c-e0ae-442f-83b4-a9350e_D2
Tumor
-0.2
0cc794c3-5bf5-4621-b238-58a0f6_D2
Tumor
-0.2
3490835c-c004-45ed-91f3-7c206f_D2
Tumor
-0.2
51c1c79e-5a8e-4b0a-bf92-1c0cab_D2
Tumor
-0.2
f6c215ea-5381-4521-bb61-be8e97_D2
Tumor
-0.2
80873a0c-1f40-4d51-bab1-3f2071_D2
Tumor
-0.2
28d0abdb-f682-4bd3-9425-a9c508_D2
Tumor
-0.3
69d552be-7cb2-4bb4-b602-a27b3e_D2
Tumor
-0.3
2224c03f-b7b1-4368-887e-2b4cdf_D2
Tumor
-0.3
347e379b-77c0-4dd3-aa25-18c9d1_D2
Tumor
-0.4
9b90eb78-2f50-4aeb-b010-d642f9_D2
Tumor
-0.4
15524912-685a-47ce-a824-567848_D2
Tumor
-0.4
a03d1103-b809-42c4-ad5c-5aff58_D2
Tumor
-0.4
2b73e01c-347a-4dae-a71d-752aeb_D2
Normal
-0.4
76e77c6b-c80e-4391-bdbb-e1dcea_D2
Tumor
-0.5
3e746bea-ed68-40e6-b348-6ddf08_D2
Normal
-0.5
685ec3c2-e67a-40d3-9eb3-aa01c9_D1_D2
Normal
-0.6
91b287fd-eadb-442d-abcd-20b741_D2
Tumor
-0.6
318d53c3-216b-4de1-a098-77d6dd_D2
Tumor
-0.6
d109a3c0-350e-47f5-bda0-61899c_D2
Tumor
-0.7
e9d416e7-f661-400a-896e-388545_D2
Tumor
-0.8
d38f40fb-dd78-43b2-8b7b-4b6977_D2
Tumor
-0.8
1b2ab076-c72f-4bbe-b9f9-657d24_D2
Tumor
-1.0
Show allShow less
OVARIAN CANCER - Protein expressioni
A mouse-over function shows sample information and annotation data. Click on an image to view it in a full screen mode. Samples can be filtered based on level of antibody staining by selecting one or several of the following categories: high, medium, low and not detected. The assay and annotation is described here.
Note that samples used for immunohistochemistry by the Human Protein Atlas do not correspond to samples in the TCGA dataset.
Antibody stainingi
Antibody staining in the annotated cell types in the current human tissue is reported as not detected, low, medium, or high, based on conventional immunohistochemistry profiling in selected tissues. This score is based on the combination of the staining intensity and fraction of stained cells.
Each image is clickable and will lead to virtual microscopy that enables deeper exploration of all samples and also displays staining intensity scores, fraction scores and subcellular localization as well as patient and tissue information for each sample.
The Human Protein Atlas project is funded
